REASSESSING SAFETY FOR NANOTECHNOLOGY COMBINATION PRODUCTS: WHAT DO BIOSIMILARS ADD TO REGULATORY CHALLENGES FOR THE FDA?Published in:St. Louis University Law Journal, 2012, v. 56, n. 2, p. 465By:Paradise, JordanPublication type:Article